Drug Safety

Controlled Trials and Risk of Harm
pp. 961-963(3)
Author: Edwards, I. Ralph

Safety of Inhaled Budesonide: Clinical Manifestations of Systemic Corticosteroid-Related Adverse Effects
pp. 965-988(24)
Authors: Christensson, Camilla; Thorén, Anders; Lindberg, Bengt

Encephalopathy after High-Dose Ifosfamide: A Retrospective Cohort Study and Review of the Literature
pp. 989-996(8)
Authors: Sweiss, Karen I.; Beri, Rakesh; Shord, Stacy S.

NSAID Use in Individuals at Risk of Renal Adverse Events: An Observational Study to Investigate Trends in Australian Veterans
pp. 997-1003(7)
Authors: Roughead, Elizabeth E.; Ramsay, Emmae; Pratt, Nicole; Gilbert, Andrew L.

Detection of Adverse Drug Events and Other Treatment Outcomes Using an Electronic Prescribing System
pp. 1005-1016(12)
Authors: Eguale, Tewodros; Tamblyn, Robyn; Winslade, Nancy; Buckeridge, David

Serious Adverse Reactions of Bupropion for Smoking Cessation: Analysis of the French Pharmacovigilance Database from 2001 to 2004
pp. 1017-1026(10)
Authors: Beyens, Marie-Nöelle; Guy, Claire; Mounier, Genevieve; Laporte, Sylvie; Ollagnier, Michel

Preventable Mix-ups of Tuberculin and Vaccines: Reports to the US Vaccine and Drug Safety Reporting Systems
pp. 1027-1033(7)
Authors: Chang, Soju; Pool, Vitali; O'Connell, Kathryn; Polder, Jacquelyn A.; Iskander, John; Sweeney, Colleen; Ball, Robert; Braun, M. Miles

Impact of Stratification on Adverse Drug Reaction Surveillance
pp. 1035-1048(14)
Authors: Hopstadius, Johan; Norén, G. Niklas; Bate, Andrew; Edwards, I. Ralph

Stratification for Spontaneous Report Databases
pp. 1049-1052(4)
Author: Evans, Stephen J.W.